Global Artificial Intelligence In Life Sciences Market: Major Trends Reshaping the Future of the Industry

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Artificial Intelligence In Life Sciences Industry Market Size Be by 2025?
The market encompassing artificial intelligence applications within life sciences has experienced a rapid surge in expansion lately; this segment is projected to escalate from a value of $2.92 billion in 2024 to $3.59 billion by 2025, reflecting an impressive compound annual growth rate of 23.2% across this period. This historical upward trajectory is fundamentally driven by several key factors, notably the escalating volume of clinical studies being conducted, the wider integration of AI technologies throughout the entire research and development spectrum, and a significant focus placed on creating highly accurate, personalized medications and drug therapies.

What's the Long-Term Growth Forecast for the Artificial Intelligence In Life Sciences Market Size Through 2029?
Exponential expansion is projected for the artificial intelligence in life sciences market over the coming years, reaching an estimated $8.42 billion by 2029, driven by a compound annual growth rate (CAGR) of 23.7%; this uptick during the projection timeframe stems from heightened engagement with real-time remote patient monitoring (rpm) solutions, a rising need for AI applications in discovering new drugs, and the wider integration of artificial intelligence for medical image analysis, while key developments set to shape this period involve strategic collaborations, novel product releases, forward-looking technological progress, increased funding, and substantial research activities.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

What Are the Key Growth Drivers Fueling the Artificial Intelligence In Life Sciences Market Expansion?
Propelled by escalating fascination with immediate remote patient monitoring (RPM) solutions, the artificial intelligence within the life sciences sector is anticipated to experience a surge in expansion moving ahead.RPM systems represent technologically advanced medical interventions intended for tracking an individual's well-being outside typical clinical environments.AI integration substantially bolsters these remote monitoring capabilities by furnishing ongoing, customized, and evidence-based perspectives, thus facilitating a more preventative approach to medical oversight.To illustrate this growth trend, data collected in August 2023 showed that physician adoption of RPM surged dramatically, escalating from 20% in 2021 to reach 81% by 2022, which marks a substantial 305% augmentation, as reported by Livelink, a US entity specializing in digital healthcare; consequently, this heightened focus on real-time RPM technologies serves as a key catalyst for the advancement of AI across the life sciences industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

What Are the Key Trends Driving Artificial Intelligence In Life Sciences Market Growth?
Key industry players within the artificial intelligence in the life sciences arena are channeling efforts into pioneering solutions incorporating sophisticated technological progress, exemplified by drug discovery software, as a strategy to maintain their market foothold. This drug discovery software constitutes a specific group of digital tools and platforms engineered to support professionals in pharmaceutical and biotech research during the early stages of identifying novel therapeutic agents. To illustrate this commitment, in December of 2023, the German science and technology giant, Merck, introduced AIDDISON, a revolutionary piece of drug discovery software; uniquely, it integrates the design of virtual molecular structures with practical considerations for actual production, leveraging generative artificial intelligence, machine learning algorithms, and computational drug design methods. AIDDISON streamlines the selection of viable drug candidates from immense datasets by simultaneously evaluating critical characteristics such as acceptable toxicity profiles and optimal solubility, thus representing a significant deployment of AI capabilities within the life sciences domain by effectively linking theoretical molecular creation with tangible production feasibility.

How Is the Artificial Intelligence In Life Sciences Market Segmented?
The artificial intelligence in life sciencesmarket covered in this report is segmented -

1) By Offering: Software; Hardware; Services
2) By Deployment: On-Premises; Cloud-Based
3) By Application: Drug Discovery; Medical Diagnosis; Biotechnology; Clinical Trails; Precision And Personalized Medicine; Patient Monitoring

Subsegments:
1) By Software: Drug Discovery Software; Genomic Analysis Software; Clinical Trial Management Software; Personalized Medicine Software; Laboratory Information Management Systems (LIMS)
2) By Hardware: AI-Enabled Laboratory Equipment; Robotics And Automation Systems; Imaging Devices And Equipment; Sensor Technologies
3) By Services: Consulting Services; Data Analytics Services; Research And Development Services; Implementation And Integration Services; Training And Support Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

Which Companies Are Leading the Charge in Artificial Intelligence In Life Sciences Market Innovation?
Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Agueda, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Inserto, Sense.ly Inc., Subtle Medical Inc., Med sense Biometrics Limited, Immune, Atomwise Inc., Freenome Holdings Inc., Clouded Inc.

Which Regions Are Leading the Global Artificial Intelligence In Life Sciences Market in Revenue?
North America was the largest region in the Artificial Intelligence In Life Sciences market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13587

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.